NEW YORK (GenomeWeb News) – Oxford Gene Technology today announced it has been awarded two grants totaling €3 million ($3.6 million) to provide genomic analysis and commercialization services for two international studies.

In one study, called EUCLIDS (EU Life-threatening Infectious Disease Study), OGT will use a five-year, €1.1 million grant to perform high-throughput genomic analysis for the identification of genomic variants that determine susceptibility and severity of life-threatening bacterial infections in children. These include meningococcal and pneumococcal cohorts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.